Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis

BACKGROUND: Individuals with sarcoidosis are at higher risk for infection owing to underlying disease pathogenesis and need for immunosuppressive treatment. Current knowledge as to how subjects with sarcoidosis respond to different forms of vaccination is limited. We examined quantitative and functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vagts, Christen L., Chang, Yi-Shin, Ascoli, Christian, Lee, Jessica M., Huang, Kai, Huang, Yue, Cherian, Ruth A., Sarup, Nandini, Warpecha, Samantha R., Edafetanure-Ibeh, Russell, Amin, Md-Ruhul, Sultana, Tasmin, Ghassemi, Mahmood, Sweiss, Nadera J., Novak, Richard, Perkins, David L., Finn, Patricia W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original research articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501840/
https://www.ncbi.nlm.nih.gov/pubmed/36601311
http://dx.doi.org/10.1183/23120541.00025-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501840/
https://www.ncbi.nlm.nih.gov/pubmed/36601311
http://dx.doi.org/10.1183/23120541.00025-2022

Ejemplares similares